Alterations of the metastasis suppressor gene nm23 and the proto- oncogene c-myc in human testicular germ cell tumors

Journal of Urology

Volumn 158, Issue 5, 1997, Pages 2000-2005

  Schmidt, Bettina ^b   Ackermann, Rolf ^b   Hartmann, Michael ^b   Strohmeyer, Torsten ^a  

^a BAYER AG   (Germany)

^b NONE

Author keywords

C myc; Metastasis; Nm23; Prognosis; Testicular germ cell tumors

Indexed keywords

ARTICLE; CANCER STAGING; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MALE; METASTASIS; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TESTIS TUMOR; TUMOR SUPPRESSOR GENE;

EID: 0030879586     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64201-0     Document Type: Article

References (44)

1. Pottern, L. M. and Goedert, J. J.: Epidemiology of testicular cancer. In: Javadpour, N. Principals and Management of Testicular Cancer, chapter 7, pp. 108-119, Thieme, New York, 1986.
2. Peckham, M.: Testicular cancer. Reviews in Oncology, 1: 439, 1988.
3. Harding, M., Hole, D. and Gills, C.: The epidemiology of non-seminomatous germ cell tumors in the West of Scotland 1975-1988. Br. J. Cancer, 72: 1559, 1995.
4. Weißbach, L. and Hildenbrand, G. Register und Verbundstudie für Hodentumore.: Ein Ergebnisbericht nach sieben Jahren. Z. Allg. Med., 60: 156, 1984.
5. Einhorn, L. H. and Donohue, J. P.: Improved chemotherapy in disseminated testicular cancer. J. Urol., 117: 65, 1977.
6. Schmoll, H. J.: Biology and treatment of testicular cancer. In: Consultant Series: The Role of Haematopoietic Growth Factors. Gardiner Caldwell Comunications Ltd., U. K., 1993.
7. Peckam, M., Barret, A., Horwich, A. and Hendry, W. F.: Orchiectomy alone for stage I testicular non-seminoma. Br. J. Urol., 55: 754, 1983.
8. Williams, S. D., Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., Spaulding, J. T., DeWys, W. D. and Crawford, E. D.: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N. Eng. J. Med., 317: 1433, 1987.
9. Bosl, G. J., Ilson, D. H., Rodriguez, E., Motzer, R. J., Reuter, V. E. and Chaganti, R. S. K.: Clinical relevance of the i(12p) marker chromosome in germ cell tumours. J. Natl. Cancer Inst., 86: 349, 1994.
10. Strohmeyer, T., Peter, S., Hartmann, M., Munemitsu, S., Ackermann, R., Ullrich, A. and Slamon, D.: Expression of the hst-1 and c-kit Proto-oncogenes in human testicular germ cell tumors. Cancer Res., 51: 1811, 1991.
11. Strohmeyer, T., Reese, D., Press, M., Ackermann, R., Hartmann, M. and Slamon, D.: Expression of the c-kit proto- oncogene and its ligand" stem cell factor (SCF)" in normal and malignant human testicular tissue. J. Urol., 153: 511, 1995.
12. Strohmeyer, T., Reissmann, P., Cordon-Cardo, C., Hartmann, M., Ackermann, R. and Slamon, D. J.: Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc. Natl. Acad. Sci., 88: 6662, 1991.
13. Steeg, P. S., Bevilaqua, G., Kopper, K., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A. and Sobel., M. E.: Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst., 80: 200, 1988.
14. Leone, A., Flato, U., King, C. R., Sandeen, M. A., Margulies, I. M., Liotta, L. A. and Steeg, P. S.: Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell, 65: 25, 1991.
15. Leone, A., Flato, U., Van Houtte, K. and Steeg, P. S.: Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene, 8: 2325, 1993.
16. Stahl, J. A., Leone, A. Rosengard, A. M., Porter, L., King, C. R. and Steeg, P. S.: Identification of a second human nm23 gene, nm23-H2. Cancer Res., 51: 445, 1991.
17. McDonald, N. J., De La Rosa, A., Benedict, M., Perez-Freije, J. M., Krutsch, H. and Steeg, P. S.: A serine phosphorylation of nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J. Biol. Chem., 268: 25780, 1993.
18. Hewlett, A. R., Petersen, O. W., Steeg, P. S. and Bissell, M. J.: A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J. Natl. Cancer Inst., 86: 1838, 1994.
19. Postel., E. H., Berberich, S. J., Flint, S. J. and Ferrone, C. A.: Human c-myc transcription factor PuF identified as nm23 H-2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis. Science, 261: 478, 1993.
20. Postel, E. H. and Ferrone, C. A.: Nucleoside diphosphate kinase enzyme activity of Nm23-H2/PuF is not required for its DNA binding and in vitro transcriptional functions. J. Biol. Chem., 269: 8627, 1994.
21. Bevilaqua, G., Sobel, M. E., Liotta, L. A. and Steeg, P. S.: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res., 49: 5185, 1989.
22. Hennessy, C., Henry, J. A., May, F. E. B., Westly, B. R., Angus, B. and Lennard, T. W. J.: Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis. J. Natl. Cancer Inst., 83: 281, 1991.
23. Barnes, R., Masood, S., Barker, E., Rosengard, A. M., Coggin, D. L., Crowell, T., King, C. R., Porter-Jordan, K., Wargotz, E. S., Liotta, L. A. and Steeg, P. S.: Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol., 139: 245, 1991.
24. Yamaguchi, A., Urano, T., Goi, T., Takeuchi, K., Niimoto, S., Nakagawara, G., Furukawa, K. and Shiku, H.: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinomas. Cancer, 73: 2280, 1994.
25. Mandai, M., Konishi, I., Koshiyama, M., Mori, T., Arao, S., Tashiro, H., Okamura, H., Nomura, H., Hiai, H. and Fukomoto, M.: Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Res., 54: 1825, 1994.
26. Nakayama, H., Yasui, W., Yokozaki, H. and Tahara, E.: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn. J. Cancer Res., 84: 184, 1993.
27. Florenes, V. A., Aamandel, S., Myklebost, O., Maelandsmo, G. M., Brulan, O. S. and Fodstad, O.: Levels of nm23 RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res., 52: 6088, 1992.
28. Engel., M., Theisinger, B., Seib, T., Seitz, G., Huwer, H., Zang, K. D., Welter, C. and Dooley, S.: High levels of nm 23-H1 and nm 23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stage. Int. J. Cancer, 55: 375, 1993.
29. Nakomori, S., Ishikawa, O., Ohhigashi, H., Kameyama, M., Furukawa, H., Sasaki, Y., Inaji, H., Higashiyama, M., Imaoka, S., Iwanaga, T., Funai, H., Wada, A. and Kimura, N.: Expression of the nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymphnode metastasis and tumor invasion. Clin. Exp. Metastasis, 11:151, 1993.
30. Myeroff, L. L. and Markowitz, S. D.: Increased nm23-H1 and nm23-H2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J. Natl. Cancer Inst., 85: 147, 1993.
31. Leone, A., Seeger, R. C., Hong, C. M., Hu, Y. Y., Arboleda, M. J., Brodeur, G. M., Stram, D., Slamon, D. J. and Steeg, P. S.: Evidence for nm23 RNA overexpression, DNA amplification and mutation in agressive childhood neuroblastomas. Oncogene, 8: 855, 1993.
32. Hailat, N., Keim, D. R., Melhem, R. F., Zhu, X., Eckerskorn, C., Brodeur, G. M., Reynolds, C. P., Seeger, R. C., Lottspeich, F., Strahler, J. R. and Hanash, S. M.: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest., 88: 341, 1991.
33. Chang, C. L., Zhu, X.-X., Thoraval, D. H., Ungar, D., Rawwas, J., Hora, N., Strahler, J. R. and Hanash, S. M.: Nm23-H1 mutation in neuroblastoma. Nature, 370: 335, 1994.
34. Wang, L., Patel, U., Ghosh, L. and Banerjee, S.: Mutations in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res., 53: 717, 1993.
35. Murty, V. V. V. S., Bosl, G. J., Houldsworth, J., Meyers, M., Mukherjee, A. B., Reuter, V. and Chaganti, R. S. K.: Allelic loss and somatic differentiation in human germ cell tumors. Oncogene, 9: 2245, 1994.
36. nd Ed., ch. 6 and 7. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
37. Feinberg, A. P. and Vogelstein, B.: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem., 132: 6, 1983.
38. Schoenfeld, A., Luqmani, Y., Smith, D., O'Reilly, S., Shousha, S., Sinnett, H. D. and Coombes, P.: Detection of breast cancer micrometastasis in axillary lymph nodes by using polymerase chain reaction. Cancer Res., 54: 2986, 1994.
39. Schumacher, J., Randles, J. W. and Riesner, D.: A two-dimensional electrophoretic technique for the detection of circular viroids and virusoids. Anal. Biochem., 135: 288, 1983.
40. Sikora, K., Evan, G., Stewart, J. and Watson, J. V.: Detection of the c-myc oncogene product in testicular cancer. Brit. J. Cancer, 52: 171, 1985.
41. Watson, J. V., Stewart, J., Evan, G., Ritson, A. and Sikora, K.: The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Brit. J. Cancer, 53: 331, 1986.
42. Peltomäki, P., Alfthan, O. and de la Chapelle, A.: Oncogenes in human testicular cancer: DNA and RNA studies. Br. J. Cancer, 63: 851, 1991.
43. Shuin, T., Misaki, H., Kubota, Y., Yao, M. and Hosaka, M.: Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer, 73: 1721, 1994.
44. Strohmeyer, T. and Slamon, D.: Proto-Oncogenes and tumor suppressor genes in human urological malignancies. J Urol., 151: 1479, 1994.